Follow
Imir G Metushi
Imir G Metushi
Director, Laboratory Corporation of America
Verified email at labcorp.com
Title
Cited by
Cited by
Year
Mechanism of isoniazid‐induced hepatotoxicity: then and now
I Metushi, J Uetrecht, E Phillips
British journal of clinical pharmacology 81 (6), 1030-1036, 2016
2212016
A fresh look at the mechanism of isoniazid‐induced hepatotoxicity
IG Metushi, P Cai, X Zhu, T Nakagawa, JP Uetrecht
Clinical Pharmacology & Therapeutics 89 (6), 911-914, 2011
2162011
T cell–mediated hypersensitivity reactions to drugs
R Pavlos, S Mallal, D Ostrov, S Buus, I Metushi, B Peters, E Phillips
Annual review of medicine 66, 439-454, 2015
1482015
Treatment of PD‐1−/− mice with amodiaquine and anti‐CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients
IG Metushi, MA Hayes, J Uetrecht
Hepatology 61 (4), 1332-1342, 2015
1472015
Detection of anti‐isoniazid and anti‐cytochrome P450 antibodies in patients with isoniazid‐induced liver failure
IG Metushi, C Sanders, TALFS Group, WM Lee, J Uetrecht
Hepatology, 2014
1412014
Automated benchmarking of peptide-MHC class I binding predictions
T Trolle, IG Metushi, JA Greenbaum, Y Kim, J Sidney, O Lund, A Sette, ...
Bioinformatics 31 (13), 2174-2181, 2015
1372015
Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats
IG Metushi, T Nakagawa, J Uetrecht
Chemical research in toxicology 25 (11), 2567-2576, 2012
1112012
Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class
A Schneir, IG Metushi, C Sloane, DJ Benaron, RL Fitzgerald
Clinical toxicology 55 (1), 51-54, 2017
692017
Animal models of idiosyncratic drug reactions
W Ng, ARM Lobach, X Zhu, X Chen, F Liu, IG Metushi, A Sharma, J Li, ...
Advances in pharmacology 63, 81-135, 2012
692012
Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset
IG Metushi, P Cai, D Dervovic, F Liu, A Lobach, T Nakagawa, J Uetrecht
Journal of immunotoxicology 12 (3), 247-260, 2015
432015
Assessment and comparison of vitreous humor as an alternative matrix for forensic toxicology screening by GC–MS
IG Metushi, RL Fitzgerald, IM McIntyre
Journal of Analytical Toxicology 40 (4), 243-247, 2016
422016
Mild isoniazid-induced liver injury in humans is associated with an increase in Th17 cells and T cells producing IL-10
IG Metushi, X Zhu, X Chen, MA Gardam, J Uetrecht
Chemical research in toxicology 27 (4), 683-689, 2014
412014
Isoniazid-induced liver injury and immune response in mice
IG Metushi, J Uetrecht
Journal of immunotoxicology 11 (4), 383-392, 2014
352014
High-dose loperamide abuse–associated ventricular arrhythmias
CW O’Connell, AA Schricker, AB Schneir, IG Metushi, ...
HeartRhythm case reports 2 (3), 232-236, 2016
232016
Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin
IG Metushi, J Uetrecht
Molecular and cellular biochemistry 387, 9-17, 2014
212014
Evaluation of the Waters MassTrak LC–MS/MS assay for tacrolimus and a comparison to the Abbott architect immunoassay
A Saitman, IG Metushi, DS Mason, RL Fitzgerald
Therapeutic drug monitoring 38 (3), 300-304, 2016
202016
Acyclovir has low but detectable influence on HLA-B* 57: 01 specificity without inducing hypersensitivity
IG Metushi, A Wriston, P Banerjee, BO Gohlke, AM English, A Lucas, ...
PLoS One 10 (5), e0124878, 2015
182015
Titanium (IV) complexes of disulfide-linked schiff bases
A Donzelli, I Metushi, PG Potvin
Inorganic Chemistry 51 (9), 5138-5145, 2012
162012
The Acute Liver Study G, Lee WM, and Uetrecht J (2014) Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure
IG Metushi, C Sanders
Hepatology 59 (3), 1084-1093, 0
15
Protein Targets of Isoniazid-Reactive Metabolites in Mouse Liver in Vivo
YM Koen, NA Galeva, IG Metushi, J Uetrecht, RP Hanzlik
Chemical Research in Toxicology 29 (6), 1064-1072, 2016
142016
The system can't perform the operation now. Try again later.
Articles 1–20